Bicara Therapeutics Inc. — Form 8-K
Filed August 25, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Bicara Therapeutics entered a sub-sublease with Wayfair LLC effective August 21, 2026 for approximately 35,090 rentable square feet on the fourth floor of 10 St. James Avenue, Boston. Base rent is $105,279 per month beginning nine months after commencement (approximately May 2027), with a two-year term ending September 30, 2028. The lease includes a $210,540 security deposit, 40 unreserved parking spaces, and permitted alterations including demountable partitions and boardroom construction.
Why this rating
Routine real estate transaction; ~$3M annualized rent is ~0.8% of company market cap—material but typical operational overhead for biotech with ~100+ employees. No strategic or financial trigger.
See more from August 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.